1.  Home
  2. Whitepapers
  3. ML7710 for Photoactivated Treatment of Lung Cancer

ML7710 for Photoactivated Treatment of Lung Cancer

Download Whitepaper

ML7710 for Photoactivated Treatment of Lung Cancer

Download Whitepaper
Photoimmunotherapy with ML7710 offers a clinical therapeutic option for NSCLC patients even with advanced disease stage. Besides laser light, this therapy involves photoactivated drug, which can be activated precisely at the tumor site with laser fibers, hence minimizing drug effects to healthy tissues. Smaller invasiveness compared to surgery can enable patients to stay less time recovering at the hospital. It can also be repeated if needed multiple times without cumulating toxicities, unlike radiation therapy. Some previously inoperable tumors can decrease in size to allow subsequent surgical resection.

Download Whitepaper Now